Faulty Glucose Monitors Recalled in Canada
Health Canada issues a recall for specific FreeStyle Libre 3 Plus sensors due to potential for incorrect glucose readings. Patients advised to check lot numbers immediately.
Health Canada issues a recall for specific FreeStyle Libre 3 Plus sensors due to potential for incorrect glucose readings. Patients advised to check lot numbers immediately.
Manitoba's official opposition calls for a mandatory standard of care for children with type-1 diabetes in schools. Parents in Winnipeg are advocating for provincial support for younger students.
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Canadian provinces face a critical health equity gap as students with diabetes navigate inconsistent support systems in schools. Learn why national standards are urgently needed.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Groundbreaking research suggests that exposure to artificial light at night could significantly increase your risk of developing cardiovascular disease and diabetes.